Organon & Co. (NYSE: OGN)’s stock price has decreased by -1.29 compared to its previous closing price of 20.12. However, the company has seen a -2.98% decrease in its stock price over the last five trading sessions. Barron’s reported on 08/12/21 that Merck Spinoff Organon Is Cheap—and It Just Set a 3.7% Dividend Yield
Is It Worth Investing in Organon & Co. (NYSE: OGN) Right Now?
Organon & Co. (NYSE: OGN) has a price-to-earnings ratio that is above its average at 6.80x. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
The average price predicted for Organon & Co. (OGN) by analysts is $30.75, which is $11.28 above the current market price. The public float for OGN is 254.22M, and at present, short sellers hold a 2.72% of that float. On May 26, 2023, the average trading volume of OGN was 2.08M shares.
OGN’s Market Performance
The stock of Organon & Co. (OGN) has seen a -2.98% decrease in the past week, with a -16.20% drop in the past month, and a -22.39% fall in the past quarter. The volatility ratio for the week is 3.21%, and the volatility levels for the past 30 days are at 3.10% for OGN. The simple moving average for the past 20 days is -9.13% for OGN’s stock, with a -23.72% simple moving average for the past 200 days.
OGN Trading at -12.07% from the 50-Day Moving Average
After a stumble in the market that brought OGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.19% of loss for the given period.
Volatility was left at 3.10%, however, over the last 30 days, the volatility rate increased by 3.21%, as shares sank -18.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.71% lower at present.
During the last 5 trading sessions, OGN fell by -2.98%, which changed the moving average for the period of 200-days by -36.73% in comparison to the 20-day moving average, which settled at $21.63. In addition, Organon & Co. saw -28.89% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for OGN
Current profitability levels for the company are sitting at:
- +27.84 for the present operating margin
- +63.07 for the gross margin
The net margin for Organon & Co. stands at +14.85. The total capital return value is set at 21.39, while invested capital returns managed to touch 11.49. Equity return is now at value -77.90, with 7.00 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 2.20, with the company’s debt to enterprise value settled at 0.59. The receivables turnover for the company is 3.96 and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.56.
Conclusion
To sum up, Organon & Co. (OGN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
